Fuzeon



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 36.7%
Hiv Infection 36.3%
Product Used For Unknown Indication 6.8%
Antiretroviral Therapy 6.1%
Hepatitis C 1.7%
Systemic Antiviral Treatment 1.7%
Depression 1.5%
Acquired Immunodeficiency Syndrome 1.1%
Hypertension 1.1%
Opportunistic Infection Prophylaxis 1.1%
Castleman's Disease 0.9%
Cytomegalovirus Infection 0.9%
Disseminated Tuberculosis 0.7%
Viral Infection 0.7%
Coronary Artery Disease 0.6%
Prophylaxis 0.6%
Sciatica 0.6%
Antiviral Prophylaxis 0.4%
Fibromyalgia 0.4%
Gout 0.4%
Death 15.4%
Injection Site Reaction 14.9%
Weight Decreased 8.0%
Pyrexia 6.3%
Disease Progression 5.7%
Umbilical Cord Abnormality 5.7%
Pneumonia 5.1%
Rash 4.0%
Lipodystrophy Acquired 3.4%
Lymphadenopathy 3.4%
Viral Load Increased 3.4%
Vomiting 3.4%
Drug Resistance 2.9%
Pancreatitis 2.9%
Paraesthesia 2.9%
Renal Failure Acute 2.9%
Weight Increased 2.9%
Drug Administration Error 2.3%
Lymphoma 2.3%
No Adverse Effect 2.3%
Secondary
Hiv Infection 54.1%
Drug Use For Unknown Indication 9.1%
Product Used For Unknown Indication 5.0%
Retroviral Infection 4.5%
Tuberculosis 3.7%
Mycobacterium Avium Complex Infection 3.2%
Systemic Antiviral Treatment 2.6%
Prophylaxis 2.1%
Drug Exposure During Pregnancy 1.9%
Disseminated Tuberculosis 1.8%
Antifungal Prophylaxis 1.6%
Anaemia 1.4%
Depression 1.4%
Acquired Immunodeficiency Syndrome 1.4%
Back Pain 1.3%
Foetal Exposure During Pregnancy 1.1%
Hiv Test Positive 1.0%
Fungal Infection 0.9%
Immune Reconstitution Syndrome 0.9%
Cytomegalovirus Infection 0.9%
Umbilical Cord Abnormality 10.9%
Lymphadenopathy 10.2%
Weight Decreased 10.2%
Subdural Haematoma 8.2%
Pyrexia 6.8%
Pancreatitis 5.4%
Stevens-johnson Syndrome 5.4%
Pancytopenia 4.1%
Plagiocephaly 4.1%
Progressive External Ophthalmoplegia 4.1%
Diaphragmatic Hernia 3.4%
Immune Reconstitution Syndrome 3.4%
Impaired Gastric Emptying 3.4%
Rhabdomyolysis 3.4%
Urticaria 3.4%
Death 2.7%
Febrile Neutropenia 2.7%
Oedema Peripheral 2.7%
Premature Baby 2.7%
Rash Morbilliform 2.7%
Concomitant
Hiv Infection 61.6%
Drug Use For Unknown Indication 16.8%
Prophylaxis 2.7%
Acquired Immunodeficiency Syndrome 2.6%
Diarrhoea 2.0%
Mycobacterium Avium Complex Infection 1.8%
Depression 1.4%
Antifungal Prophylaxis 1.3%
Product Used For Unknown Indication 1.3%
Hypertension 1.1%
Antiviral Prophylaxis 0.9%
Insomnia 0.9%
Pneumocystis Jiroveci Pneumonia 0.8%
Antibiotic Prophylaxis 0.8%
Hiv Test Positive 0.8%
Antiretroviral Therapy 0.7%
Candidiasis 0.7%
Anxiety 0.6%
Convulsion 0.6%
Pain 0.6%
Vomiting 9.3%
Thrombocytopenia 8.8%
Mental Status Changes 8.4%
Renal Failure 7.9%
Pyrexia 7.0%
Weight Decreased 6.5%
Renal Failure Acute 6.0%
Haemorrhage Intracranial 5.1%
Transaminases Increased 4.2%
Varices Oesophageal 4.2%
Liver Function Test Abnormal 3.7%
Rash Maculo-papular 3.7%
Squamous Cell Carcinoma 3.7%
Hepatitis 3.3%
Immune Reconstitution Syndrome 3.3%
Meningitis Cryptococcal 3.3%
Subdural Haematoma 3.3%
Hypertension 2.8%
Hypothermia 2.8%
Syncope 2.8%